Compare TOWN & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOWN | IMNM |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.2B |
| IPO Year | 1999 | 2020 |
| Metric | TOWN | IMNM |
|---|---|---|
| Price | $37.04 | $24.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $31.22 |
| AVG Volume (30 Days) | 514.3K | ★ 2.1M |
| Earning Date | 01-28-2026 | 03-18-2026 |
| Dividend Yield | ★ 2.91% | N/A |
| EPS Growth | ★ 2.79 | N/A |
| EPS | ★ 2.21 | N/A |
| Revenue | ★ $811,780,000.00 | $9,679,000.00 |
| Revenue This Year | $35.38 | N/A |
| Revenue Next Year | $7.01 | $11.53 |
| P/E Ratio | $16.78 | ★ N/A |
| Revenue Growth | ★ 16.92 | N/A |
| 52 Week Low | $29.43 | $5.15 |
| 52 Week High | $38.01 | $27.65 |
| Indicator | TOWN | IMNM |
|---|---|---|
| Relative Strength Index (RSI) | 63.76 | 57.35 |
| Support Level | $34.34 | $23.86 |
| Resistance Level | $37.69 | $27.65 |
| Average True Range (ATR) | 1.04 | 1.63 |
| MACD | 0.13 | -0.08 |
| Stochastic Oscillator | 89.88 | 62.94 |
Towne Bank is a financial services company that places special emphasis on serving the financial needs of individuals, commercial enterprises, and professionals, offering retail and commercial banking services to numerous markets in Virginia and North Carolina. The company has three reportable segments: the Banking Segment provides loan and deposit services to retail and commercial customers and provides commercial mortgage brokerage services and investment and asset management services, and the Realty Segment provides residential real estate services and mortgage loans. It also provides resort property management and residential and commercial title insurance, and the Insurance Segment provides a wide array of insurance products, including property, casualty, life, and health insurance.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.